Rhythm Pharmaceuticals to Present at Wells Fargo Healthcare Conference in September
PremiumPress ReleasesRhythm Pharmaceuticals to Present at Wells Fargo Healthcare Conference in September
25d ago
Rhythm Pharmaceuticals Announces FDA Acceptance for Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide) in Patients as Young as 2 years old
Premium
Press Releases
Rhythm Pharmaceuticals Announces FDA Acceptance for Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide) in Patients as Young as 2 years old
25d ago
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Premium
Press Releases
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
1M ago
Rhythm Pharmaceuticals Announces European Commission Expands ▼IMCIVREE® (setmelanotide) Marketing Authorization to include Children as Young as 2 Years Old
PremiumPress ReleasesRhythm Pharmaceuticals Announces European Commission Expands ▼IMCIVREE® (setmelanotide) Marketing Authorization to include Children as Young as 2 Years Old
2M ago
Rhythm Pharmaceuticals announces expansion of IMCIVREE marketing authorization
Premium
The Fly
Rhythm Pharmaceuticals announces expansion of IMCIVREE marketing authorization
2M ago
Rhythm announces first patients dosed in Phase 2 trial of LB54640
Premium
The Fly
Rhythm announces first patients dosed in Phase 2 trial of LB54640
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100